Skip to content

Medical device manufacturer

Roche Diagnostics Corporation

Roche Diagnostics Corporation holds 455 FDA 510(k) clearances across 146 product codes. Median elapsed review time is 74 days. openFDA lists 240 recall records naming the company. FDA publishes it under 8 different spellings, all counted here as one company.

Updated · ingest status · JSON

510(k) clearances
455
Product codes
146
Median review
74 days
Recall records
240

How does FDA spell Roche Diagnostics Corporation?

FDA publishes this company under 8 different spellings across its datasets. Every figure on this page counts all of them as one company, which is why the totals here are higher than a search for any single spelling would give you.

Every spelling FDA published for this company, and which dataset each came from.
As FDA published itDatasetMatched by
ROCHE DIAGNOSTICS GMBHdevice/registrationlistingnormalised
Roche Diagnosticsdevice/510knormalised
Roche Diagnostics Corp.device/recallnormalised
Roche Diagnostics Corp.device/510knormalised
Roche Diagnostics Corporationdevice/enforcementnormalised
Roche Diagnostics Corporationdevice/recallnormalised
Roche Diagnostics Corporationdevice/510knormalised
Roche Diagnostics GmbHdevice/510knormalised

Merges are measured against a hand-labelled sample and held above 98% precision. Pairs the matcher is unsure of are queued for a person rather than merged, because two genuinely different firms with similar names is the error that would corrupt every count on this page.

Which product codes does Roche Diagnostics Corporation file in?

146 product codes, ranked by how much they file in each.

Product codes this company holds clearances in, with their median elapsed review time in each.
CodeDeviceClearancesMedian reviewLatest
JJXSingle (Specified) Analyte Controls (Assayed And Unassayed)6048 days
JJYMulti-Analyte Controls, All Kinds (Assayed)2237 days
NBWSystem, Test, Blood Glucose, Over The Counter1974 days
JITCalibrator, Secondary1828 days
GJSTest, Time, Prothrombin14108 days
JIXCalibrator, Multi-Analyte Mixture1438 days
LFRGlucose Dehydrogenase, Glucose1229 days
DKZEnzyme Immunoassay, Amphetamine1068 days
CGNAcid, Folic, Radioimmunoassay7140 days
JZOSystem, Test, Thyroid Autoantibody7119 days
NBCTest, Natriuretic Peptide7166 days
CFRHexokinase, Glucose640 days
MMIImmunoassay Method, Troponin Subunit669 days
DKBCalibrators, Drug Mixture562 days
JISCalibrator, Primary521 days
LCMEnzyme Immunoassay, Phencyclidine562 days
LCPAssay, Glycosylated Hemoglobin5190 days
CDZRadioimmunoassay, Testosterones And Dihydrotestosterone4114 days
CEMElectrode, Ion Specific, Potassium428 days
CEWRadioimmunoassay, Parathyroid Hormone449 days
CIGDiazo Colorimetry, Bilirubin449 days
DCNSystem, Test, C-Reactive Protein4106 days
DFCLipoprotein, Low-Density, Antigen, Antiserum, Control449 days
DIOEnzyme Immunoassay, Cocaine And Cocaine Metabolites466 days
JGSElectrode, Ion Specific, Sodium497 days

Showing the 25 they file in most, of 146.

Median review is elapsed calendar days between date received and decision date, as published by FDA. It is not FDA review days — the two differ whenever the agency stops the clock for an additional information request.

Source: openFDA device/510k · retrieved

Has Roche Diagnostics Corporation had a recall?

openFDA lists 240 recall records naming this company across its whole history. A recall record covers one firm's corrective action and may span many device lots.

  • Z-1979-2019Class IITerminatedCZP

    Calibration failures with Std.E, Sens.E, or Dup.E error due to atypical reaction kinetics and quality control failures have occurred due to contamination of R1 reagent with R3 reagent.

  • Z-1927-2019Class IIITerminatedJQP

    There is a potential for the tray input flap on the post analytical units to become loose, potentially detaching from the instrument.

  • Z-1928-2019Class IIITerminatedJQP

    There is a potential for the tray input flap on the post analytical units to become loose, potentially detaching from the instrument.

  • Z-1194-2019Class IITerminatedCJW

    The reagent lot is exhibiting calibration failures, QC imprecision, and elevated QC recovery due to elevated pH level causing higher absorbance values.

  • Z-1249-2019Class IITerminatedJJE

    The firm has confirmed complaints regarding signal drops on the cobas e 801 module after a ProCell II M bottle changeover, which may lead to incorrect medical decisions with respect to diagnostics and patient treatment.

Showing the 5 most recently initiated of 240.

Recall class comes from openFDA's enforcement endpoint, which does not carry every recall — where it is missing, none is shown rather than guessed. Recall class I is the most serious kind of recall; device class I is the least risky kind of device, and the two are never mixed here.

Source: openFDA device/recall · retrieved

What has Roche Diagnostics Corporation cleared recently?

Most recent 510(k) clearances for this company, newest first.
510(k)DeviceCodeDecisionElapsed days
K252323cobas pulse blood glucose monitoring systemPZI322
K252431Elecsys CalcitoninJKR266
K252280Elecsys Anti-SARS-CoV-2 SQVP265
K260049Elecsys Anti-HBc IgMSEI90
K260048Elecsys Anti-HAV IgMLOL90
K260046Elecsys Anti-HBc IISEI90
K260026Tina-quant Cardiac high sensitivity CRP IIINQD87
K253491ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integrated solutionsCEM111
K253490Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutionsCFR111
K253839Elecsys Anti-SARS-CoV-2QVP16

Source: openFDA device/510k · retrieved

Where is Roche Diagnostics Corporation registered?

FDA lists 2 registered establishments for this company in US.

Registration means the firm has told FDA it makes or distributes devices from that site. It is not a clearance, an approval or an endorsement.

Watch what Roche Diagnostics Corporation files next

Get an email when this company clears a new device, or when anything is recalled in a product code you follow.

Start watching with DeviceSignal

Data on this page comes from FDA's public openFDA API and is US public domain (CC0). DeviceSignal is an independent commercial service and is not affiliated with the U.S. Food and Drug Administration. Information only, not regulatory advice. Verify anything you rely on against open.fda.gov.